Infectious disease severe

Because of overuse of antibiotics and/or weakened governmental surveillance of infectious disease, several diseases that had been thought to be no longer a threat to human health (e.g., pneumonia and tuberculosis) are rapidly becoming unman-... 

Most of the herbal drugs that are used medicinally are comprised in these five groups of indications. Relative few are employed in a limited number of other areas occasionally in skm remedies, liver remedies, coronary remedies, blood circulation remedies, and in other groups of medicines. Summarizing, it can be said that the possibilities of treatment with herbal drugs are limited for a number of reasons for a series of illnesses like severe cardiac insufficiency, tumours, infectious diseases, diabetes, etc., herbal drugs arc not adequate remedies, even though, in contravention of the law, such claims are made in many publications. In a series of further cases, they only find use in support of the actual medical treatment they are nevertheless of value. 

Several TLR-4 adjuvants for vaccines have been developed to date. An example of these is monopho-sphoryl lipid A (MJPL) a modified version of lipid A found in LPS [4]. It has been used extensively in clinical trials as it is far less toxic than LPS. It is hoped to use MPL in vaccines against infectious diseases, allergies and cancer. Derivatives of MPL have now been... 

TLR-9 has also been used to target asthma with several compounds in preclinical trials such as second generation CpG-ODNs and HYB2093. 1018 ISS has also been tested in asthma. Defence against infectious disease is also enhanced through TLR-9. CpGIOlOl was in phase II trails as a Hepatitis C target but has been discontinued. 

The available water resources are linked to human health in several ways water for drinking, hygiene, recreational activities and food production. As water resources decrease as a consequence of droughts or increased demand, the need to use water sources of poor quality appears, and consequently the risk of an increase in the occurrence of outbreaks of infectious diseases related to water can be higher. 

A variety of other clinically important infections, such as brucellosis, listeriosis, salmonellosis, and various Mycobacterium infections, are of interest as these are often localized in organs rich in MPS cells. Liposome encapsulation has been demonstrated to improve therapeutic indices of several drugs in a number of infectious models. The natural avidity of macrophages for liposomes can also be exploited in the application of the vesicles as carriers of immunomodulators to activate these cells to an microbicidal, antiviral, or tumoricidal state. These studies were recently reviewed by Emmen and Storm (1987), Popescu et al. (1987), and Alving (1988). In addition to the treatment of "old" infectious diseases, the concept of MPS-directed drug delivery is of considerable interest for the therapy AIDS, possibly enabling control of human immunodeficiency virus replication in human macrophages. 

A feature that is common to vaccines, immunosera and human immunoglobulins is the maiked specificity of their actions. Each provides immunity to only one infection. This specificity has led to the development of vaccines and immunosera with several different components such as are present in the widely used diphtheria/tetanus/pertussis vaccines that are used to prevent the infectious diseases that commonly afflict infants and young children. 

There is the potential to develop a protective vaccine/immunization programme for each and every infectious disease. Whether or not such vaccines are developed and deployed is related to the severity and economic impact of the disease upon the eommunity as well as the effects upon the individual. Principles of immunity and of the produetion and quality control of immunological products are discussed in Chapters 14 and 15, respeetively. 

Table 74—2 presents the recommended agents for treatment of community-acquired and complicated intraabdominal infections from the Infectious Diseases Society of America and the Surgical Infection Society.21-23 These recommendations were formulated using an evidence-based approach. Most community-acquired infections are mild to moderate, whereas health care-associated infections tend to be more severe and difficult to treat. Table 74-3 presents guidelines for treatment and alternative regimens for specific situations. These are general guidelines there are many factors that cannot be incorporated into such a table. 

Implications for pathogenesis. A recent study showed that the plasma levels of IL-6 and LPS-binding protein are associated with the severity of adverse reactions after diethylcarbamazine treatment of microfilaraemic patients (Haarbrink et al., 2000, Journal of Infectious Diseases 182, 564—569). The authors discuss the possibility that Wolbachia LPS are involved in the side effects of therapy. 

In some patients believed to suffer from the irritable bowel syndrome, an underlying enteric neuromuscular disorder has later been identified [133]. The bridge to infectious diseases is also of interest, with several entero-tropic viruses in focus, and reports of lymphocytic infiltration of enteric neural structures in patients with unexplained intestinal dysmotility require further studies. 

Influenza is one of the most common infectious diseases in humankind and is one of the most contagious airborne infectious diseases. The natural reservoirs are humans, horses, swine, and birds. It can survive outside a host in dried mucous for several hours. This is a biosafety level 2 agent. 

Several CSF preparations have gained regulatory approval (Table 10.2). G-CSF and GM-CSF have proven useful in the treatment of neutropenia. All three CSF types are (or are likely to be) useful also in the treatment of infectious diseases, some forms of cancer and the management of bone marrow transplants, as they stimulate the differentiation/activation of white blood cell types most affected by such conditions. 

Polyclonal antibody preparations have been used for several decades to induce passive immunization against infectious diseases and other harmful agents, particularly toxins. The antibody preparations are usually administered by direct i.v. injection. While this affords immediate immunological protection, its effect is transitory, usually persisting for only 2-3 weeks (i.e. until the antibodies are excreted). Passive immunization can be used prophylactically (i.e. to prevent a future medical episode) or therapeutically (i.e. to treat a medical condition that is already established). An example of the former would be prior administration of a specific anti-snake toxin antibody preparation to an individual before they travel to a world region in which these snakes are commonly found. An example of the latter would be administration of the anti-venom antibody immediately after the individual has experienced a snake bite. 

Reliable information on the epidemiology, disease severity, and effect on public health is essential to sustain the need for a vaccine. The authorities must develop the policy to prevent infectious diseases and in the same time countermeasures against effects of biological weapons attack. 

Considerable data is available suggesting thatmild-to-moderate immunosuppression can lead to an increase in infectious disease. The types of infections that occur tend to result from either common pathogens (e.g., causing upper respiratory tract infections) or latent viruses (e.g., herpes cold sores), rather than opportunistic organisms such as Pnuemocyctis carinii. These are usually not life-threatening, except in certain susceptible populations, such as the elderly. Opportunistic infections, in contrast, are more prevalent in individuals where severe forms of immunosuppression are present, such as primary immunodeficiency diseases or HIV/AIDS. 

---